Philips is banned from selling new devices against sleep apnea in the United States. The Dutch giant has recalled 5.5 million of these devices out of a total of 15 million.
Philips has already taken 1 billion euros in provisions, and, in September, it agreed to settle a dispute worth at least 479 million dollars. The group could also be the subject of class actions in the U.S. or be sued by thousands of users. The Philips respirator scandal began in June 2021. Since June 2021, its market capitalization has been halved.